PD-1, PD-L1 Protein Expression in Non-Small Cell Lung Cancer and Their Relationship with Tumor-Infiltrating Lymphocytes

BACKGROUND: Immunotherapy targeting the programmed death-1 (PD-1)/programmed death ligand-1 (PD-L1) checkpoint has shown the good outcomes in non-small cell lung cancer (NSCLC). We investigated PD-1 and PD-L1 protein expression and their correlation with tumor-infiltrating lymphocytes (TILs), and as...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Yayi, Rozeboom, Leslie, Rivard, Christopher J., Ellison, Kim, Dziadziuszko, Rafał, Yu, Hui, Zhou, Caicun, Hirsch, Fred R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356616/
https://www.ncbi.nlm.nih.gov/pubmed/28275222
http://dx.doi.org/10.12659/MSM.899909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356616/
https://www.ncbi.nlm.nih.gov/pubmed/28275222
http://dx.doi.org/10.12659/MSM.899909

Ejemplares similares